Principal Investigator
Maria Carpintero
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20231048
Clinical Trial Summary
Novartis-CVAY736F12301-A randomized, double-blind, parallel group, placebo controlled, multicenter phase 3 study to evaluate efficacy, safety and tolerability of two regimens of ianalumab on top of standard-of-care therapy in patients with systemic lupus erythematosus (SIRIUS-SLE 1)
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other
Contact Information
Study Contact
Niurka Colina
Phone Number
+1 (305) 2436405
Email
nxc610@miami.edu